SKIP TO MAIN CONTENT

Why is Pfizer's rollout of its anti-COVID pill so slow?

SBS News In Depth

Follow and Subscribe

Virus Outbreak Pfizer
In this photo provided by Pfizer, a lab technician visually inspects Paxlovid tablet samples in Freiburg, Germany in December 2021. Studies showed that the first pill to treat the virus led to a nearly 90% reduction in hospitalizations and deaths among patients most likely to get severe disease. (Pfizer via AP) Credit: thomas hansmann.fotograf/AP

Pfizer's COVID-19 treatment pill Paxlovid was the first pill authoriSed in the U-S to treat coronavirus. But since its approval, there have been questions as to why it takes so long to make.

Follow and Subscribe

Apple Podcasts Spotify Listnr Download (10.76MB)
Download the SBS Audio appAvailable on iOS and Android

Published

By Tina Quinn

Source: SBS News

Skip to podcast episode content

Pfizer's COVID-19 treatment pill Paxlovid was the first pill authoriSed in the U-S to treat coronavirus. But since its approval, there have been questions as to why it takes so long to make.

Latest podcast episodes

Get SBS News straight to your inbox

Sign up now for daily news from Australia and around the world. You can also subscribe to Insight's weekly newsletter for in-depth features and first-person stories.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

Follow SBS News

Download our apps

Listen to our podcasts

Get the latest with our News podcasts on your favourite podcast apps.

Watch on SBS

SBS World News

Take a global view with Australia's most comprehensive world news service

Stream now

Watch the latest news videos from Australia and across the world